CN Stock MarketDetailed Quotes

300760 Shenzhen Mindray Bio-Medical Electronics

Watchlist
  • 309.00
  • -3.76-1.20%
Market Closed May 17 15:00 CST
374.64BMarket Cap30.78P/E (TTM)

Shenzhen Mindray Bio-Medical Electronics Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
12.06%9.37B
15.04%34.93B
17.20%27.3B
20.32%18.48B
20.47%8.36B
20.17%30.37B
20.13%23.3B
20.17%15.36B
20.10%6.94B
20.18%25.27B
Operating revenue
12.06%9.37B
15.04%34.93B
17.20%27.3B
20.32%18.48B
20.47%8.36B
20.17%30.37B
20.13%23.3B
20.17%15.36B
20.10%6.94B
20.18%25.27B
Other operating revenue
----
378.66%56.61M
----
319.44%21.91M
----
0.82%11.83M
----
25.02%5.22M
----
-73.87%11.73M
Total operating cost
8.99%6.07B
10.92%21.99B
14.62%16.55B
19.74%11.45B
20.36%5.57B
18.95%19.83B
19.16%14.44B
19.24%9.56B
16.38%4.63B
19.91%16.67B
Operating cost
13.50%3.19B
8.59%11.82B
11.24%9.25B
15.40%6.36B
16.00%2.81B
23.10%10.89B
24.69%8.32B
25.20%5.51B
19.84%2.42B
20.05%8.84B
Operating tax surcharges
19.06%100.81M
5.11%366.08M
13.51%288.04M
17.27%185.21M
6.57%84.67M
23.51%348.29M
17.80%253.77M
15.20%157.93M
31.85%79.45M
29.63%281.99M
Operating expense
8.13%1.49B
18.77%5.7B
19.78%3.99B
31.72%2.83B
28.04%1.37B
20.07%4.8B
17.12%3.33B
14.77%2.15B
12.75%1.07B
10.72%4B
Administration expense
3.56%473.35M
15.43%1.52B
19.86%1.12B
28.58%795.64M
27.54%457.08M
19.39%1.32B
10.35%930.89M
4.82%618.81M
10.38%358.38M
23.21%1.11B
Financial expense
-2,005.68%-123.74M
-89.54%-854.91M
-25.56%-604.99M
-156.10%-571.56M
23.49%-5.88M
-424.62%-451.04M
-460.38%-481.83M
-418.38%-223.18M
-124.00%-7.68M
-39.97%-85.97M
-Interest expense (Financial expense)
71.67%4.47M
21.62%13M
15.71%8.82M
15.19%5.55M
15.15%2.6M
23.77%10.69M
21.74%7.62M
15.30%4.81M
34.27%2.26M
--8.63M
-Interest Income (Financial expense)
-37.07%-189.76M
-129.57%-821.64M
-107.87%-526.34M
-67.48%-292.21M
-56.25%-138.44M
12.13%-357.91M
19.44%-253.21M
21.92%-174.47M
12.15%-88.6M
-5.61%-407.32M
Research and development
11.16%947.43M
17.45%3.43B
20.19%2.51B
37.13%1.85B
21.07%852.3M
15.78%2.92B
28.11%2.09B
27.19%1.35B
19.74%703.95M
35.03%2.52B
Credit Impairment Loss
-40.35%-66.41M
-563.32%-244.19M
-489.62%-60.42M
-749.41%-56.87M
-840.64%-47.32M
-733.20%-36.81M
63.95%-10.25M
71.79%-6.7M
-188.61%-5.03M
119.59%5.81M
Asset Impairment Loss
-2.10%-43.45M
-644.80%-529.51M
-148.73%-120.05M
-169.50%-76.85M
-107.55%-42.56M
46.03%-71.09M
27.33%-48.27M
22.07%-28.52M
-372.68%-20.5M
-19.49%-131.73M
Other net revenue
152.53%272.94M
-71.40%129.16M
23.55%445.12M
43.27%305.72M
22.19%108.08M
-2.60%451.63M
12.77%360.29M
29.79%213.39M
-13.74%88.46M
40.56%463.68M
Fair value change income
--126.03M
471.42%79.4M
384.58%60.84M
255.19%33.18M
----
-316.40%-21.38M
-381.92%-21.38M
-216.68%-21.38M
--7.83M
--9.88M
Invest income
-183.94%-3.1M
-94.43%-9.84M
-24.47%-4.95M
30.20%-1.8M
6.92%-1.09M
-723.73%-5.06M
-90.34%-3.98M
-68.55%-2.58M
38.22%-1.17M
118.15%811.48K
-Including: Investment income associates
-183.94%-3.1M
-108.97%-9.82M
-26.32%-5.02M
40.12%-1.54M
6.92%-1.09M
-678.93%-4.7M
-90.34%-3.98M
-68.55%-2.58M
38.22%-1.17M
118.15%811.48K
Asset deal income
46.80%-316.18K
-60.02%2.46M
-28.90%4.32M
-114.86%-113.62K
91.08%-594.32K
51.61%6.16M
113.10%6.08M
-51.77%764.43K
-2,429.24%-6.66M
296.67%4.07M
Other revenue
30.33%260.19M
43.29%830.84M
29.06%565.38M
50.18%408.18M
75.13%199.64M
0.87%579.82M
4.80%438.08M
17.44%271.79M
10.88%114M
20.68%574.84M
Operating profit
23.20%3.57B
18.92%13.07B
21.49%11.2B
22.06%7.33B
20.74%2.9B
21.23%10.99B
21.38%9.22B
22.00%6.01B
26.05%2.4B
21.60%9.07B
Add:Non operating Income
-17.63%7.47M
59.70%56.35M
29.23%36.13M
13.48%18.18M
77.50%9.07M
51.81%35.28M
66.84%27.96M
40.66%16.02M
51.34%5.11M
-56.70%23.24M
Less:Non operating expense
4.16%22.04M
59.56%115.28M
165.45%49.84M
193.69%38.35M
2,146.26%21.16M
0.52%72.25M
-34.17%18.77M
-25.63%13.06M
-84.08%941.95K
2.10%71.87M
Total profit
23.21%3.56B
18.78%13.01B
21.23%11.19B
21.66%7.31B
20.03%2.89B
21.48%10.95B
21.69%9.23B
22.21%6.01B
26.44%2.41B
21.22%9.02B
Less:Income tax cost
25.59%395.92M
6.68%1.43B
20.40%1.35B
20.70%866.58M
5.53%315.26M
32.56%1.34B
22.26%1.12B
25.78%717.94M
59.64%298.73M
30.07%1.01B
Net profit
22.92%3.16B
20.47%11.58B
21.34%9.84B
21.79%6.44B
22.09%2.57B
20.07%9.61B
21.61%8.11B
21.74%5.29B
22.82%2.11B
20.19%8B
Net profit from continuing operation
22.92%3.16B
20.47%11.58B
21.34%9.84B
21.79%6.44B
22.09%2.57B
20.07%9.61B
21.61%8.11B
21.74%5.29B
22.82%2.11B
20.19%8B
Less:Minority Profit
54.87%1.89M
-207.62%-3.81M
-64.60%1.22M
-53.59%1.22M
-35.72%1.22M
42.15%3.54M
41.22%3.45M
145.75%2.63M
283.11%1.9M
29.32%2.49M
Net profit of parent company owners
22.90%3.16B
20.56%11.58B
21.38%9.83B
21.83%6.44B
22.14%2.57B
20.07%9.61B
21.60%8.1B
21.71%5.29B
22.74%2.11B
20.19%8B
Earning per share
Basic earning per share
22.80%2.6107
20.38%9.5586
21.30%8.1216
21.76%5.3187
22.36%2.126
20.55%7.9402
22.14%6.6955
22.24%4.3682
23.17%1.7375
20.27%6.5868
Diluted earning per share
22.80%2.6091
20.42%9.5577
21.25%8.1185
21.69%5.3157
22.28%2.1247
20.50%7.9369
22.14%6.6955
22.24%4.3682
23.17%1.7375
20.27%6.5868
Other composite income
-2,363.48%-116.26M
-9.26%272.83M
59.46%199.12M
925.22%322.17M
106.30%5.14M
204.70%300.67M
224.24%124.87M
212.38%31.42M
-1,150.51%-81.52M
-136.80%-287.16M
Other composite income of parent company owners
-2,240.44%-109.94M
-9.65%271.65M
59.46%199.12M
925.22%322.17M
106.30%5.14M
204.70%300.67M
224.24%124.87M
212.38%31.42M
-1,150.51%-81.52M
-136.80%-287.16M
Other composite income of minority owners
---6.32M
--1.19M
----
----
----
----
----
----
----
----
Total composite income
18.16%3.05B
19.57%11.85B
21.92%10.03B
27.13%6.77B
27.25%2.58B
28.44%9.91B
25.38%8.23B
23.26%5.32B
17.53%2.03B
18.03%7.72B
Total composite income of parent company owners
18.39%3.05B
19.64%11.85B
21.95%10.03B
27.17%6.76B
27.31%2.58B
28.43%9.91B
25.37%8.23B
23.23%5.32B
17.46%2.02B
18.02%7.71B
Total composite income of minority owners
-462.44%-4.43M
-174.16%-2.63M
-64.60%1.22M
-53.59%1.22M
-35.72%1.22M
42.15%3.54M
41.22%3.45M
145.75%2.63M
283.11%1.9M
29.32%2.49M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 12.06%9.37B15.04%34.93B17.20%27.3B20.32%18.48B20.47%8.36B20.17%30.37B20.13%23.3B20.17%15.36B20.10%6.94B20.18%25.27B
Operating revenue 12.06%9.37B15.04%34.93B17.20%27.3B20.32%18.48B20.47%8.36B20.17%30.37B20.13%23.3B20.17%15.36B20.10%6.94B20.18%25.27B
Other operating revenue ----378.66%56.61M----319.44%21.91M----0.82%11.83M----25.02%5.22M-----73.87%11.73M
Total operating cost 8.99%6.07B10.92%21.99B14.62%16.55B19.74%11.45B20.36%5.57B18.95%19.83B19.16%14.44B19.24%9.56B16.38%4.63B19.91%16.67B
Operating cost 13.50%3.19B8.59%11.82B11.24%9.25B15.40%6.36B16.00%2.81B23.10%10.89B24.69%8.32B25.20%5.51B19.84%2.42B20.05%8.84B
Operating tax surcharges 19.06%100.81M5.11%366.08M13.51%288.04M17.27%185.21M6.57%84.67M23.51%348.29M17.80%253.77M15.20%157.93M31.85%79.45M29.63%281.99M
Operating expense 8.13%1.49B18.77%5.7B19.78%3.99B31.72%2.83B28.04%1.37B20.07%4.8B17.12%3.33B14.77%2.15B12.75%1.07B10.72%4B
Administration expense 3.56%473.35M15.43%1.52B19.86%1.12B28.58%795.64M27.54%457.08M19.39%1.32B10.35%930.89M4.82%618.81M10.38%358.38M23.21%1.11B
Financial expense -2,005.68%-123.74M-89.54%-854.91M-25.56%-604.99M-156.10%-571.56M23.49%-5.88M-424.62%-451.04M-460.38%-481.83M-418.38%-223.18M-124.00%-7.68M-39.97%-85.97M
-Interest expense (Financial expense) 71.67%4.47M21.62%13M15.71%8.82M15.19%5.55M15.15%2.6M23.77%10.69M21.74%7.62M15.30%4.81M34.27%2.26M--8.63M
-Interest Income (Financial expense) -37.07%-189.76M-129.57%-821.64M-107.87%-526.34M-67.48%-292.21M-56.25%-138.44M12.13%-357.91M19.44%-253.21M21.92%-174.47M12.15%-88.6M-5.61%-407.32M
Research and development 11.16%947.43M17.45%3.43B20.19%2.51B37.13%1.85B21.07%852.3M15.78%2.92B28.11%2.09B27.19%1.35B19.74%703.95M35.03%2.52B
Credit Impairment Loss -40.35%-66.41M-563.32%-244.19M-489.62%-60.42M-749.41%-56.87M-840.64%-47.32M-733.20%-36.81M63.95%-10.25M71.79%-6.7M-188.61%-5.03M119.59%5.81M
Asset Impairment Loss -2.10%-43.45M-644.80%-529.51M-148.73%-120.05M-169.50%-76.85M-107.55%-42.56M46.03%-71.09M27.33%-48.27M22.07%-28.52M-372.68%-20.5M-19.49%-131.73M
Other net revenue 152.53%272.94M-71.40%129.16M23.55%445.12M43.27%305.72M22.19%108.08M-2.60%451.63M12.77%360.29M29.79%213.39M-13.74%88.46M40.56%463.68M
Fair value change income --126.03M471.42%79.4M384.58%60.84M255.19%33.18M-----316.40%-21.38M-381.92%-21.38M-216.68%-21.38M--7.83M--9.88M
Invest income -183.94%-3.1M-94.43%-9.84M-24.47%-4.95M30.20%-1.8M6.92%-1.09M-723.73%-5.06M-90.34%-3.98M-68.55%-2.58M38.22%-1.17M118.15%811.48K
-Including: Investment income associates -183.94%-3.1M-108.97%-9.82M-26.32%-5.02M40.12%-1.54M6.92%-1.09M-678.93%-4.7M-90.34%-3.98M-68.55%-2.58M38.22%-1.17M118.15%811.48K
Asset deal income 46.80%-316.18K-60.02%2.46M-28.90%4.32M-114.86%-113.62K91.08%-594.32K51.61%6.16M113.10%6.08M-51.77%764.43K-2,429.24%-6.66M296.67%4.07M
Other revenue 30.33%260.19M43.29%830.84M29.06%565.38M50.18%408.18M75.13%199.64M0.87%579.82M4.80%438.08M17.44%271.79M10.88%114M20.68%574.84M
Operating profit 23.20%3.57B18.92%13.07B21.49%11.2B22.06%7.33B20.74%2.9B21.23%10.99B21.38%9.22B22.00%6.01B26.05%2.4B21.60%9.07B
Add:Non operating Income -17.63%7.47M59.70%56.35M29.23%36.13M13.48%18.18M77.50%9.07M51.81%35.28M66.84%27.96M40.66%16.02M51.34%5.11M-56.70%23.24M
Less:Non operating expense 4.16%22.04M59.56%115.28M165.45%49.84M193.69%38.35M2,146.26%21.16M0.52%72.25M-34.17%18.77M-25.63%13.06M-84.08%941.95K2.10%71.87M
Total profit 23.21%3.56B18.78%13.01B21.23%11.19B21.66%7.31B20.03%2.89B21.48%10.95B21.69%9.23B22.21%6.01B26.44%2.41B21.22%9.02B
Less:Income tax cost 25.59%395.92M6.68%1.43B20.40%1.35B20.70%866.58M5.53%315.26M32.56%1.34B22.26%1.12B25.78%717.94M59.64%298.73M30.07%1.01B
Net profit 22.92%3.16B20.47%11.58B21.34%9.84B21.79%6.44B22.09%2.57B20.07%9.61B21.61%8.11B21.74%5.29B22.82%2.11B20.19%8B
Net profit from continuing operation 22.92%3.16B20.47%11.58B21.34%9.84B21.79%6.44B22.09%2.57B20.07%9.61B21.61%8.11B21.74%5.29B22.82%2.11B20.19%8B
Less:Minority Profit 54.87%1.89M-207.62%-3.81M-64.60%1.22M-53.59%1.22M-35.72%1.22M42.15%3.54M41.22%3.45M145.75%2.63M283.11%1.9M29.32%2.49M
Net profit of parent company owners 22.90%3.16B20.56%11.58B21.38%9.83B21.83%6.44B22.14%2.57B20.07%9.61B21.60%8.1B21.71%5.29B22.74%2.11B20.19%8B
Earning per share
Basic earning per share 22.80%2.610720.38%9.558621.30%8.121621.76%5.318722.36%2.12620.55%7.940222.14%6.695522.24%4.368223.17%1.737520.27%6.5868
Diluted earning per share 22.80%2.609120.42%9.557721.25%8.118521.69%5.315722.28%2.124720.50%7.936922.14%6.695522.24%4.368223.17%1.737520.27%6.5868
Other composite income -2,363.48%-116.26M-9.26%272.83M59.46%199.12M925.22%322.17M106.30%5.14M204.70%300.67M224.24%124.87M212.38%31.42M-1,150.51%-81.52M-136.80%-287.16M
Other composite income of parent company owners -2,240.44%-109.94M-9.65%271.65M59.46%199.12M925.22%322.17M106.30%5.14M204.70%300.67M224.24%124.87M212.38%31.42M-1,150.51%-81.52M-136.80%-287.16M
Other composite income of minority owners ---6.32M--1.19M--------------------------------
Total composite income 18.16%3.05B19.57%11.85B21.92%10.03B27.13%6.77B27.25%2.58B28.44%9.91B25.38%8.23B23.26%5.32B17.53%2.03B18.03%7.72B
Total composite income of parent company owners 18.39%3.05B19.64%11.85B21.95%10.03B27.17%6.76B27.31%2.58B28.43%9.91B25.37%8.23B23.23%5.32B17.46%2.02B18.02%7.71B
Total composite income of minority owners -462.44%-4.43M-174.16%-2.63M-64.60%1.22M-53.59%1.22M-35.72%1.22M42.15%3.54M41.22%3.45M145.75%2.63M283.11%1.9M29.32%2.49M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg